Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 561

1.

Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

Pelosi G, Fraggetta F, Pasini F, Maisonneuve P, Sonzogni A, Iannucci A, Terzi A, Bresaola E, Valduga F, Lupo C, Viale G.

Am J Surg Pathol. 2001 Mar;25(3):363-72.

PMID:
11224607
2.

Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.

Puglisi F, Barbone F, Damante G, Bruckbauer M, Di Lauro V, Beltrami CA, Di Loreto C.

Mod Pathol. 1999 Mar;12(3):318-24.

PMID:
10102618
3.

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G.

Hum Pathol. 2003 Jun;34(6):597-604.

PMID:
12827614
4.

Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.

Ritter JH, Dresler CM, Wick MR.

Hum Pathol. 1995 Nov;26(11):1227-32.

PMID:
7590697
5.

Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers.

Takahama M, Tsutsumi M, Tsujiuchi T, Kido A, Okajima E, Nezu K, Tojo T, Kushibe K, Kitamura S, Konishi Y.

Jpn J Clin Oncol. 1998 Mar;28(3):176-81.

PMID:
9614439
6.

Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.

Castro CY, Stephenson M, Gondo MM, Medeiros LJ, Cagle PT.

Mod Pathol. 2000 Jul;13(7):808-13.

7.
8.

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G.

J Pathol. 2002 Sep;198(1):100-9.

PMID:
12210069
9.

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.

Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL.

Br J Cancer. 2001 Sep 14;85(6):881-90.

10.

CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients.

Pelosi G, Barisella M, Pasini F, Leon ME, Veronesi G, Spaggiari L, Fraggetta F, Iannucci A, Masullo M, Sonzogni A, Maffini F, Viale G.

Mod Pathol. 2004 Jun;17(6):711-21.

12.

Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.

Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A, Terzi A, De Manzoni G, Bresaola E, Viale G.

Cancer. 2003 May 15;97(10):2487-97.

13.

Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.

Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K.

Oncol Rep. 2005 Jun;13(6):1075-80.

PMID:
15870924
15.
16.

Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.

Aikawa H, Takahashi H, Fujimura S, Sato M, Endo C, Sakurada A, Kondo T, Tanita T, Matsumura Y, Ono S, Saito Y, Sagawa M.

Anticancer Res. 1999 Sep-Oct;19(5B):4305-9.

PMID:
10628391
17.

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

Ohsaki Y, Tanno S, Fujita Y, Toyoshima E, Fujiuchi S, Nishigaki Y, Ishida S, Nagase A, Miyokawa N, Hirata S, Kikuchi K.

Oncol Rep. 2000 May-Jun;7(3):603-7.

PMID:
10767376
18.

Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers.

Harada T, Ogura S, Yamazaki K, Kinoshita I, Itoh T, Isobe H, Yamashiro K, Dosaka-Akita H, Nishimura M.

Cancer Sci. 2003 Apr;94(4):394-9.

19.

Comparison of human lung cancer/SCID mouse tumor xenografts and cell culture growth with patient clinical outcomes.

Anderson TM, Hess SD, Egilmez NK, Nwogu CE, Lenox JM, Bankert RB.

J Cancer Res Clin Oncol. 2003 Oct;129(10):565-8. Epub 2003 Aug 16.

PMID:
12923636
20.

Supplemental Content

Support Center